The role of angiotensin system inhibitors (ASIs) in the outcome of sunitinib treatment (tx) in patients (pts) with metastatic renal cell carcinoma (mRCC).
J. J. Kim
No relevant relationships to disclose
P. Huang
No relevant relationships to disclose
M. A. Eisenberger
No relevant relationships to disclose
R. Pili
No relevant relationships to disclose
E. S. Antonarakis
No relevant relationships to disclose
H. J. Hammers
No relevant relationships to disclose
M. A. Carducci
No relevant relationships to disclose
D. Keizman
No relevant relationships to disclose